Novo Nordisk's pricing procedures during the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of selling price gouging, mentioning the stark distinction involving U.S. prices and those in Europe and copyright. Difficulties with diabetic ret